Relmada Therapeutics (RLMD) Debt to Equity (2014 - 2018)
Relmada Therapeutics (RLMD) reported Debt to Equity of -$0.89 for Q3 2018, down 140.67% year-over-year from $2.18 in Q3 2017, and up 28.57% on a QoQ basis from -$1.24 in Q2 2018.
Relmada Therapeutics (RLMD) has 5 years of Debt to Equity data on file, last reported at -$0.89 in Q3 2018.
- Quarterly Debt to Equity fell 140.67% year-over-year to -$0.89 in Q3 2018, while the trailing twelve-month figure through Sep 2018 was -$0.89 (down 140.67% YoY) and the FY2018 annual result came in at -$1.24, down 1131.94% from the prior year.
- Debt to Equity grew to -$0.89 in Q3 2018 per RLMD's latest filing, from -$1.24 in the prior quarter.
- Across five years, Debt to Equity topped out at $9.81 in Q1 2015 and bottomed at -$23.07 in Q2 2014.
- The 5-year median for Debt to Equity is $0.12 (2017), against an average of -$0.14.
- The widest annual swing landed in 2017, when Debt to Equity surged 6043.44%; it then slumped 2495.95% in 2018.
- Tracing RLMD's Debt to Equity over 5 years: stood at $5.79 in 2014, then slumped by 97.88% to $0.12 in 2015, then retreated by 8.9% to $0.11 in 2016, then surged by 6043.44% to $6.88 in 2017, then slumped by 112.9% to -$0.89 in 2018.
- Per Business Quant, the three latest RLMD Debt to Equity figures stand at -$0.89 (Q3 2018), -$1.24 (Q2 2018), and -$2.39 (Q1 2018).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt/Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 0.06 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Relmada Therapeutics | 595.35 Mn | 595.35 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2018 | -0.89 |
| Jun 30, 2018 | -1.24 |
| Mar 31, 2018 | -2.39 |
| Dec 31, 2017 | 6.88 |
| Sep 30, 2017 | 2.18 |
| Jun 30, 2017 | 0.12 |
| Mar 31, 2017 | 0.10 |
| Dec 31, 2016 | 0.11 |
| Sep 30, 2016 | 0.17 |
| Jun 30, 2016 | 0.13 |
| Mar 31, 2016 | 0.06 |
| Dec 31, 2015 | 0.12 |
| Sep 30, 2015 | 0.34 |
| Jun 30, 2015 | 1.59 |
| Mar 31, 2015 | 9.81 |
| Dec 31, 2014 | 5.79 |
| Sep 30, 2014 | -2.26 |
| Jun 30, 2014 | -23.07 |